Association between Circulating Thrombopoeitin Levels and Cardiovascular Risk Prediction Scores in Renal Transplant Recipients.
CONCLUSION: TPO levels are increased in RTR with high CRCRTR-MACE, particularly in smokers with diminished eGFR. Circulating TPO may serve as a biomarker and treatment target for CVD in RTR. © 2015 S. Karger AG, Basel.
PMID: 25824430 [PubMed - as supplied by publisher]
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Mansell H, Elmoselhi H, Shoker A Tags: Am J Nephrol Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Smokers | Study | Transplants | Urology & Nephrology